| Symbol
| BCR-ABL
|
| Location
| 22q11 or 9q34
|
| Name
|
Philadelphia chromosome |
| Other name(s)
|
chronic myeloid leukemia (MIM 608232) |
| Corresponding gene
|
ABL1
, BCR
|
| Other symbol(s)
| CML, Ph1
|
| Main clinical features
|
chronic myeloid leukemia (CML) or T cell acute lymphoblastic/myeloblastic leukemia, clonal myeloproliferative disorders of a pluripotent stem cell with a specific cytogenetic abnormality, thePhiladelphia chromosome (Ph) |
Genetic determination
| Function/system disorder
| hematology |
| Type
| malignancy
| |
| Name
| BCR-ABL fusion gene encoding a tyrosine kinase with two alternative chimeric proteins p210 (BCR-ABL) and p185 (BCR-ABL)
|
| Gene mutation | Chromosome rearrangement | Effect | Comments |
|
|---|
|  
| translocation
| abnormal protein/gain of function
| somatic t(9;22)(q34.1;q11.21)
| |  
| translocation
| abnormal protein/gain of function
| various cytogenetic forms with more or less complex rearrangements in BCR-ABL +, Ph1 - leukemias
| |
| Remark(s)
|
mRNA interacting with the xeroderma pigmentosum group B protein XPB/ERCC3 |